Novo Nordisk (NVO) is down -14.7%, or -$6.97 to $40.45.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NVO:
- Morning Movers: Arcellx skyrockets following pact to be acquired
- Novo Nordisk Advances DKK 15 Billion Share Buyback, Lifts Treasury Stake to 0.5%
- Novo Nordisk downgraded to Hold from Buy at Deutsche Bank
- Deutsche ‘throwing in the towel,’ downgrades Novo Nordisk to Hold
- Novo Nordisk’s CagriSema Misses Non‑Inferiority Goal but Delivers 23% Weight Loss in REDEFINE 4 Trial